Reverse Medical Raises $14M

Irvine-based Reverse Medical Corporation, a developer of microcatheters for treating neurovascular disorders, announced today that it has raised $14M in a Series B funding round. The firm said that the new funding came from Wexford Capital, Getz Bros., BioStar Ventures, Early Stage Partners, and Emergent Medical Partners--all new investors--along with prior investors NBGI Ventures, MedFocus Funds and South Australian Life Science Advancement Partnership. The firm's products are used to treat strokes. Reverse Medical said the funding will go towards commercialization of its products. More information »